DK1032596T3 - Fremgangsmåde til fremstilling af lactalbumin - Google Patents

Fremgangsmåde til fremstilling af lactalbumin

Info

Publication number: DK1032596T3
Authority: DK; Denmark
Prior art keywords: lactalbumin; alpha; oligomeric form; producing; ion exchange
Prior art date: 1997-11-21

Application number

DK98955823T

Other languages

English (en)

Inventor

Catharina Svanborg

Per Anders Hakansson

Malin Wilhelmina Svensson

Original Assignee

Nya Hamlet Pharma Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-21

Filing date

1998-11-23

Publication date

2007-09-10

1997-11-21 Priority claimed from GBGB9724725.8A external-priority patent/GB9724725D0/en

1998-11-23 Application filed by Nya Hamlet Pharma Ab filed Critical Nya Hamlet Pharma Ab

2007-09-10 Application granted granted Critical

2007-09-10 Publication of DK1032596T3 publication Critical patent/DK1032596T3/da

Links

102000004407 Lactalbumin Human genes 0.000 title abstract 7
108090000942 Lactalbumin Proteins 0.000 title abstract 7
238000000034 method Methods 0.000 title abstract 2
235000021241 α-lactalbumin Nutrition 0.000 abstract 6
239000005018 casein Substances 0.000 abstract 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 2
235000021240 caseins Nutrition 0.000 abstract 2
238000005342 ion exchange Methods 0.000 abstract 2
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
101000946377 Bos taurus Alpha-lactalbumin Proteins 0.000 abstract 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
239000005642 Oleic acid Substances 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
235000020256 human milk Nutrition 0.000 abstract 1
210000004251 human milk Anatomy 0.000 abstract 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
238000002203 pretreatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Toxicology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)

DK98955823T 1997-11-21 1998-11-23 Fremgangsmåde til fremstilling af lactalbumin DK1032596T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9724725.8A GB9724725D0 (en)	1997-11-21	1997-11-21	Protein production process
GBGB9812202.1A GB9812202D0 (en)	1997-11-21	1998-06-05	Protein production process
PCT/IB1998/001919 WO1999026979A1 (en)	1997-11-21	1998-11-23	Lactalbumin production process

Publications (1)

Publication Number	Publication Date
DK1032596T3 true DK1032596T3 (da)	2007-09-10

Family

ID=26312643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98955823T DK1032596T3 (da)	1997-11-21	1998-11-23	Fremgangsmåde til fremstilling af lactalbumin

Country Status (9)

Country	Link
US (2)	US7053185B1 (da)
EP (1)	EP1032596B1 (da)
JP (1)	JP2001524491A (da)
AT (1)	ATE361319T1 (da)
AU (1)	AU1254199A (da)
DE (1)	DE69837719T2 (da)
DK (1)	DK1032596T3 (da)
ES (1)	ES2286860T3 (da)
WO (1)	WO1999026979A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1210949B1 (en) *	1999-07-28	2008-11-19	Morinaga Milk Industry Co., Ltd.	Lactalbumin for the curative treatment of peptic ulcers
US20030077255A1 (en) *	2001-04-16	2003-04-24	Sabharwal Hemant K.	Compositions of bacteria and alpha-lactalbumin and uses thereof
GB0205347D0 (en) *	2002-03-07	2002-04-24	Svanborg Catharina	Biologically active complex
GB0210464D0 (en)	2002-05-08	2002-06-12	Svanborg Catharina	Therapeutic treatment
WO2007088869A1 (ja) *	2006-02-01	2007-08-09	National University Corporation Hokkaido University	ラクトアルブミン変性物の製造方法
WO2008138348A1 (en) *	2007-05-09	2008-11-20	Nya Hamlet Pharma Ab	Preparation of complexed lactalbumin
US8796218B2 (en)	2009-01-09	2014-08-05	Hamlet Pharma Ab	Complex and production process
ES2613986T3 (es)	2010-11-24	2017-05-29	Hamlet Pharma Ab	Complejo biológicamente activo y su preparación
EP2869831A4 (en)	2012-07-05	2016-04-06	Univ New York State Res Found	POTENTIATING AN ANTIBIOTIC TREATMENT WITH A PROTEIN LIPID COMPLEX
HUE038910T2 (hu)	2012-08-09	2018-12-28	Hamlet Pharma Ab	Profilaktikus és gyógytáp terápia
CN104399065A (zh) *	2014-10-17	2015-03-11	广东海洋大学	一种可诱导人乳腺癌细胞凋亡的牛乳蛋白脂肪酸修饰物及其制备方法
EP3815763A1 (de) *	2019-11-01	2021-05-05	I3 Membrane GmbH	Verfahren und vorrichtung zur gleichspannungsgesteuerten adsorption und desorption an geladenen membranen
US20260108588A1 (en)	2022-10-03	2026-04-23	Linnane Pharma Ab	A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer
GB202303177D0 (en)	2023-03-03	2023-04-19	Linnane Pharma Ab	Method of predicting response to treatment
WO2025186107A1 (en)	2024-03-04	2025-09-12	Linnane Pharma Ab	Therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2961625B2 (ja) *	1991-01-21	1999-10-12	雪印乳業株式会社	α−ラクトアルブミン含有量の高い組成物の製造方法
AU7792294A (en) *	1994-08-16	1996-03-07	Hemant Sabharwal	Antibacterial composition containing multimeric alpha-lactalbumin

1998
- 1998-11-23 DK DK98955823T patent/DK1032596T3/da active
- 1998-11-23 EP EP98955823A patent/EP1032596B1/en not_active Expired - Lifetime
- 1998-11-23 DE DE69837719T patent/DE69837719T2/de not_active Expired - Lifetime
- 1998-11-23 AU AU12541/99A patent/AU1254199A/en not_active Abandoned
- 1998-11-23 WO PCT/IB1998/001919 patent/WO1999026979A1/en not_active Ceased
- 1998-11-23 AT AT98955823T patent/ATE361319T1/de not_active IP Right Cessation
- 1998-11-23 ES ES98955823T patent/ES2286860T3/es not_active Expired - Lifetime
- 1998-11-23 US US09/554,704 patent/US7053185B1/en not_active Expired - Fee Related
- 1998-11-23 JP JP2000522135A patent/JP2001524491A/ja active Pending
2006
- 2006-01-27 US US11/275,760 patent/US7524932B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69837719T2 (de)	2008-01-31
JP2001524491A (ja)	2001-12-04
US20060229436A1 (en)	2006-10-12
ES2286860T3 (es)	2007-12-01
US7524932B2 (en)	2009-04-28
WO1999026979A1 (en)	1999-06-03
EP1032596B1 (en)	2007-05-02
US7053185B1 (en)	2006-05-30
ATE361319T1 (de)	2007-05-15
DE69837719D1 (de)	2007-06-14
EP1032596A1 (en)	2000-09-06
AU1254199A (en)	1999-06-15

Similar Documents

Publication	Publication Date	Title
DK1032596T3 (da)	2007-09-10	Fremgangsmåde til fremstilling af lactalbumin
IL95480A0 (en)	1991-06-30	Process for the preparation of cyclic amino acids,and intermediates
HUP9900920A2 (hu)	1999-07-28	Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
DE69532760D1 (de)	2004-04-29	Mittel zur verabreichung von antigenen
MY137329A (en)	2009-01-30	Process of transferring a thin layer including an over-weakening phase
DE69328776D1 (de)	2000-07-06	Rekonstruiertes knorpelgewebe
EP0187048A3 (en)	1988-09-21	Process for the production of soy hydrolysate, enzymatically modified soy protein and the use thereof as an egg white substitute
LV12189A (lv)	1998-12-20	Panemiens N-amino-1-hidroksialkiliden-1,1-bifosfon-skabju iegusanai
ATE123925T1 (de)	1995-07-15	Verfahren zur herstellung eines enzymhydrolysates.
ES8104412A1 (es)	1981-04-16	Procedimiento para la preparacion de un hidrolizado de pro- teinas purificado.
DK1204738T3 (da)	2006-06-06	Fremgangsmåde til nedsættelse af skumdannelsen under dyrkning af en mikroorganisme
DK1329462T3 (da)	2007-01-22	Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
AU7506396A (en)	1997-05-29	Composition for improving pancreatic function
ES2159519T3 (es)	2001-10-16	Procedimiento para producir/secretar una proteina por un moho transformado usando regiones de regulacion de la expresion/secrecion derivadas de un gen de endoxilanasa ii de aspergillus.
PT86358A (fr)	1988-01-01	Procede de fabrication d:une hydrolysat enzymatique de proteines riche en di et tri-peptides utilisable notamment en nutrution artificielle et en dietetique
HU903524D0 (en)	1990-10-28	Process for producing purified albumin solutions
DE3568048D1 (en)	1989-03-09	Process for the synthesis of peptides
BG104801A (en)	2001-04-30	Indole-2,3-dione-3-oxime derivatives for therapeutical use
FI973469A0 (fi)	1997-08-22	Menetelmä tekijän IX valmistamiseksi biologisista lähteistä
SE8502315D0 (sv)	1985-05-09	Improved transamination process for producing amino acids
HU902754D0 (en)	1991-12-30	Process for producing germinal biphosphonic acids and derivatives thereof
AU4102300A (en)	2000-09-14	Method for preparing albumin hydrolysates
NZ333412A (en)	2000-10-27	Plant proteins treated to reduce isoflavones, manganese and nucleotides and nutritional products made therefrom
DE69126563D1 (de)	1997-07-24	Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
MXPA02000801A (es)	2004-03-19	Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.